Market Research

eClinical Solutions Market (Solution Type: Clinical Trial Management Systems, Electronic Clinical Outcome Assessment, Randomization & Trial Supply Management, Electronic Data Capture & Clinical Data Management, Electronic Trial Master Files, Patient Recru

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 235 Pages Transparency Market Research Pvt. Ltd. August, 2023 TNPR18249865
Best Price Guarantee
Price from $5,795
Length 235 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date August, 2023
SKU TNPR18249865

eClinical Solutions Market (Solution Type: Clinical Trial Management Systems, Electronic Clinical Outcome Assessment, Randomization & Trial Supply Management, Electronic Data Capture & Clinical Data Management, Electronic Trial Master Files, Patient Recruitment, Regulatory Information Management System, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


eClinical Solutions Market – Scope of Report

TMR’s report on the global eClinical solutions market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global eClinical solutions market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global eClinical solutions market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the eClinical solutions market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global eClinical solutions market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global eClinical solutions market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global eClinical solutions market.

The report delves into the competitive landscape of the global eClinical solutions market. Key players operating in the global eClinical solutions market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global eClinical solutions market profiled in this report.

Key Questions Answered in Global eClinical Solutions Market Report
  • What is the sales/revenue generated by eClinical solutions across all regions during the forecast period?
  • What are the opportunities in the global eClinical solutions market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
eClinical Solutions Market – Research Objectives and Research Approach

The comprehensive report on the global eClinical solutions market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global eClinical solutions market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global eClinical solutions market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global eClinical Solutions Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global eClinical Solutions Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario, by Region
5.3. Value Chain Analysis
5.4. COVID-19 impact on the Industry
6. Global eClinical Solutions Market Analysis and Forecast, by Solution Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Solution Type, 2017-2031
6.3.1. Clinical Trial Management Systems
6.3.2. Electronic Clinical Outcome Assessment
6.3.3. Randomization & Trial Supply Management
6.3.4. Electronic Data Capture & Clinical Data Management
6.3.5. Electronic Trial Master Files
6.3.6. Patient Recruitment
6.3.7. Regulatory Information Management Systems
6.3.8. Others
6.4. Market Attractiveness Analysis, by Solution Type
7. Global eClinical Solutions Market Analysis and Forecast, by Delivery Mode
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Delivery Mode, 2017-2031
7.3.1. Licensed Enterprise/On-premise
7.3.2. Web-based
7.3.3. Others
7.3.4. Cloud-based/Software-as-a-service (SaaS)
7.4. Market Attractiveness Analysis, by Delivery Mode
8. Global eClinical Solutions Market Analysis and Forecasts, by Clinical Trial Phase
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Clinical Trial Phase, 2017-2031
8.3.1. Phase I
8.3.2. Phase II
8.3.3. Phase III
8.3.4. Phase IV
8.4. Market Attractiveness Analysis, by Clinical Trial Phase
9. Global eClinical Solutions Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. Medical Device Manufacturers
9.3.3. Contract Research Organizations
9.3.4. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global eClinical Solutions Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America eClinical Solutions Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Solution Type, 2017-2031
11.2.1. Clinical Trial Management Systems
11.2.2. Electronic Clinical Outcome Assessment
11.2.3. Randomization & Trial Supply Management
11.2.4. Electronic Data Capture & Clinical Data Management
11.2.5. Electronic Trial Master Files
11.2.6. Patient Recruitment
11.2.7. Regulatory Information Management Systems
11.2.8. Others
11.3. Market Value Forecast, by Delivery Mode, 2017-2031
11.3.1. Licensed Enterprise/On-premise
11.3.2. Web-based
11.3.3. Others
11.3.4. Cloud-based/Software-as-a-service (SaaS)
11.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
11.4.1. Phase I
11.4.2. Phase II
11.4.3. Phase III
11.4.4. Phase IV
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. Medical Device Manufacturers
11.5.3. Contract Research Organizations
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Solution Type
11.7.2. By Delivery Mode
11.7.3. By Clinical Trial Phase
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe eClinical Solutions Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Solution Type, 2017-2031
12.2.1. Clinical Trial Management Systems
12.2.2. Electronic Clinical Outcome Assessment
12.2.3. Randomization & Trial Supply Management
12.2.4. Electronic Data Capture & Clinical Data Management
12.2.5. Electronic Trial Master Files
12.2.6. Patient Recruitment
12.2.7. Regulatory Information Management Systems
12.2.8. Others
12.3. Market Value Forecast, by Delivery Mode, 2017-2031
12.3.1. Licensed Enterprise/On-premise
12.3.2. Web-based
12.3.3. Others
12.3.4. Cloud-based/Software-as-a-service (SaaS)
12.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
12.4.1. Phase I
12.4.2. Phase II
12.4.3. Phase III
12.4.4. Phase IV
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. Medical Device Manufacturers
12.5.3. Contract Research Organizations
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Solution Type
12.7.2. By Delivery Mode
12.7.3. By Clinical Trial Phase
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific eClinical Solutions Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Solution Type, 2017-2031
13.2.1. Clinical Trial Management Systems
13.2.2. Electronic Clinical Outcome Assessment
13.2.3. Randomization & Trial Supply Management
13.2.4. Electronic Data Capture & Clinical Data Management
13.2.5. Electronic Trial Master Files
13.2.6. Patient Recruitment
13.2.7. Regulatory Information Management Systems
13.2.8. Others
13.3. Market Value Forecast, by Delivery Mode, 2017-2031
13.3.1. Licensed Enterprise/On-premise
13.3.2. Web-based
13.3.3. Others
13.3.4. Cloud-based/Software-as-a-service (SaaS)
13.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
13.4.1. Phase I
13.4.2. Phase II
13.4.3. Phase III
13.4.4. Phase IV
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Pharmaceutical & Biotechnology Companies
13.5.2. Medical Device Manufacturers
13.5.3. Contract Research Organizations
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Solution Type
13.7.2. By Delivery Mode
13.7.3. By Clinical Trial Phase
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America eClinical Solutions Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Solution Type, 2017-2031
14.2.1. Clinical Trial Management Systems
14.2.2. Electronic Clinical Outcome Assessment
14.2.3. Randomization & Trial Supply Management
14.2.4. Electronic Data Capture & Clinical Data Management
14.2.5. Electronic Trial Master Files
14.2.6. Patient Recruitment
14.2.7. Regulatory Information Management Systems
14.2.8. Others
14.3. Market Value Forecast, by Delivery Mode, 2017-2031
14.3.1. Licensed Enterprise/On-premise
14.3.2. Web-based
14.3.3. Others
14.3.4. Cloud-based/Software-as-a-service (SaaS)
14.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
14.4.1. Phase I
14.4.2. Phase II
14.4.3. Phase III
14.4.4. Phase IV
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Pharmaceutical & Biotechnology Companies
14.5.2. Medical Device Manufacturers
14.5.3. Contract Research Organizations
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Solution Type
14.7.2. By Delivery Mode
14.7.3. By Clinical Trial Phase
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa eClinical Solutions Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Solution Type, 2017-2031
15.2.1. Clinical Trial Management Systems
15.2.2. Electronic Clinical Outcome Assessment
15.2.3. Randomization & Trial Supply Management
15.2.4. Electronic Data Capture & Clinical Data Management
15.2.5. Electronic Trial Master Files
15.2.6. Patient Recruitment
15.2.7. Regulatory Information Management Systems
15.2.8. Others
15.3. Market Value Forecast, by Delivery Mode, 2017-2031
15.3.1. Licensed Enterprise/On-premise
15.3.2. Web-based
15.3.3. Others
15.3.4. Cloud-based/Software-as-a-service (SaaS)
15.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
15.4.1. Phase I
15.4.2. Phase II
15.4.3. Phase III
15.4.4. Phase IV
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Pharmaceutical & Biotechnology Companies
15.5.2. Medical Device Manufacturers
15.5.3. Contract Research Organizations
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Solution Type
15.7.2. By Delivery Mode
15.7.3. By Clinical Trial Phase
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. ArisGlobal LLC
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Clario
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. eClinical Solutions LLC
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Evidation Health, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Florence Healthcare
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Advarra, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Dassault Systèmes S.E. (Medidata)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Medrio, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Oracle Corporation
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Parexel Corporation
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Signant Health
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Veeva Systems Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Viedoc Technologies
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. MedNet Solutions
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
16.3.15. Anju Software, Inc.
16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.15.2. Product Portfolio
16.3.15.3. Financial Overview
16.3.15.4. SWOT Analysis
16.3.15.5. Strategic Overview
16.3.16. Other Prominent Players
16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.16.2. Product Portfolio
16.3.16.3. Financial Overview
16.3.16.4. SWOT Analysis
16.3.16.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings